Your browser doesn't support javascript.
loading
Investigating chromosomal instability in long-term survivors with glioblastoma and grade 4 astrocytoma.
Spoor, Jochem K H; den Braber, May; Dirven, Clemens M F; Pennycuick, Adam; Bartkova, Jirina; Bartek, Jiri; van Dis, Vera; van den Bosch, Thierry P P; Leenstra, Sieger; Venkatesan, Subramanian.
Afiliação
  • Spoor JKH; Department of Neurosurgery, Brain Tumor Center, Erasmus University Medical Center, Rotterdam, Netherlands.
  • den Braber M; Department of Paediatric Neurosurgery, Erasmus Medical Center Sophia Children's Hospital, Rotterdam, Netherlands.
  • Dirven CMF; Department of Neurosurgery, Brain Tumor Center, Erasmus University Medical Center, Rotterdam, Netherlands.
  • Pennycuick A; Department of Neurosurgery, Brain Tumor Center, Erasmus University Medical Center, Rotterdam, Netherlands.
  • Bartkova J; Lungs for Living Research Centre, UCL Respiratory, Division of Medicine, University College London, London, United Kingdom.
  • Bartek J; Genome Integrity Group, Danish Cancer Institute, Danish Cancer Society, Copenhagen, Denmark.
  • van Dis V; Division of Genome Biology, Department of Medical Biochemistry and Biophysics, Science for Life Laboratory, Karolinska Institute, Stockholm, Sweden.
  • van den Bosch TPP; Genome Integrity Group, Danish Cancer Institute, Danish Cancer Society, Copenhagen, Denmark.
  • Leenstra S; Division of Genome Biology, Department of Medical Biochemistry and Biophysics, Science for Life Laboratory, Karolinska Institute, Stockholm, Sweden.
  • Venkatesan S; Department of Pathology, Erasmus University Medical Center, Rotterdam, Netherlands.
Front Oncol ; 13: 1218297, 2023.
Article em En | MEDLINE | ID: mdl-38260852
ABSTRACT

Background:

Only a small group of patients with glioblastoma multiforme (GBM) survives more than 36 months, so-called long-term survivors. Recent studies have shown that chromosomal instability (CIN) plays a prognostic and predictive role among different cancer types. Here, we compared histological (chromosome missegregation) and bioinformatic metrics (CIN signatures) of CIN in tumors of GBM typical survivors (≤36 months overall survival), GBM long-term survivors and isocitrate dehydrogenase (IDH)-mutant grade 4 astrocytomas.

Methods:

Tumor sections of all gliomas were examined for anaphases and chromosome missegregation. Further CIN signature activity analysis in the The Cancer Genome Atlas (TCGA)-GBM cohort was performed.

Results:

Our data show that chromosome missegregation is pervasive in high grade gliomas and is not different between the 3 groups. We find only limited evidence of altered CIN levels in tumors of GBM long-term survivors relative to the other groups, since a significant depletion in CIN signature 11 relative to GBM typical survivors was the only alteration detected. In contrast, within IDH-mutant grade 4 astrocytomas we detected a significant enrichment of CIN signature 5 and 10 activities and a depletion of CIN signature 1 activity relative to tumors of GBM typical survivors.

Conclusions:

Our data suggest that CIN is pervasive in high grade gliomas, however this is unlikely to be a major contributor to the phenomenon of long-term survivorship in GBM. Nevertheless, further evaluation of specific types of CIN (signatures) could have prognostic value in patients suffering from grade 4 gliomas.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Front Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Front Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda